Concerns growing over controversial rebates

The controversy over rebates and the “right'' price for drugs have been ongoing topics of debate as Korea’s leading pharmaceutical firms are in more fierce competition to raise their revenues.

Consumers and civic groups have been furious that illegal practice was commonplace in the domestic pharmaceutical industry, which impedes their right to access quality drugs for treatment.

The Korea...